Genoray Co., Ltd. (KOSDAQ:122310)
3,125.00
-15.00 (-0.48%)
At close: Nov 13, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 39.79 billion as of November 13, 2026. It is the 33,706th most valuable company in the world and the 1,919th biggest in South Korea. Its market cap has decreased by 30.86% in one year.
Market Cap
39.79B
Enterprise Value
55.45B
Revenue
107.88B
Global Rank
Country Rank
#1,919 South Korea
PE Ratio
14.97
ChartMarket Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 39.79B, a decrease of -73.56%. That is a compound annual growth rate of -14.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 39.79B | -21.27% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hironic | 66.90B |
| SELVAS Healthcare | 58.25B |
| DRGEM | 53.66B |
| Dynamic solution | 50.97B |
| JPI Healthcare | 38.95B |
| BTB Korea Co.,Ltd | 37.08B |
| QuantaMatrix | 36.75B |
| Genesystem | 31.32B |